COVID-19: Council updates recommendation on restrictions to travel from third countries

20.05.2021
Brussels

EU News 127/2021

The Council today adopted an amending recommendation on the temporary restriction on non-essential travel into the EU. This amendment responds to the ongoing vaccination campaigns by introducing certain waivers for vaccinated persons and easing the criteria to lift restrictions for third countries. At the same time, it takes into account the possible risks posed by new variants by setting out an emergency brake mechanism to quickly react to the emergence of a variant of interest or concern in a third country.

Criteria to lift restrictions for all travellers from a third country

For restrictions on non-essential travel to be lifted for a given third country, under the new rules the number of COVID-19 cases per 100 000 inhabitants over the last 14 days is raised from 25 to 75. The progress in having the population vaccinated against the virus should also be taken into account. At the same time, to respond to the risk posed by new variants, the detection in a country of variants of interest should now be considered together with variants of concern.

Other existing criteria continue to apply, including a stable or decreasing trend of new cases, the number of tests performed, a 4% positivity rate among all tests carried out, the overall response to COVID-19 in the country and the reliability of the available information. Reciprocity should continue to be taken into account on a case by case basis.

Lifting of restrictions for vaccinated persons

If member states accept proof of vaccination to waive travel restrictions such as testing or quarantine, they should in principle lift restrictions on non-essential travel for third-country travellers who have received the last recommended dose of an EMA approved vaccine at least 14 days before arrival. Member states could also lift the restriction on non-essential travel to those who have received at least 14 days before the last recommended dose of a vaccine having completed the WHO emergency use listing process.

Where lifting these restrictions, member states should take into account reciprocity on a case by case basis.

See also